These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10440537)

  • 1. Effects of activation of renal adenosine A2 receptor on renal function and renin release in dogs.
    Miura K; Okumura M; Yamanaka S; Kim S; Iwao H
    Jpn J Pharmacol; 1999 Jun; 80(2):173-6. PubMed ID: 10440537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
    Webb RL; Barclay BW; Graybill SC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor.
    Levens N; Beil M; Schulz R
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1013-9. PubMed ID: 2046018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
    Levens N; Beil M; Jarvis M
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle.
    Bokník P; Neumann J; Schmitz W; Scholz H; Wenzlaff H
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):750-8. PubMed ID: 9436814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
    Hutchison AJ; Webb RL; Oei HH; Ghai GR; Zimmerman MB; Williams M
    J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adenosine receptor agonists on renal function in anaesthetized rats.
    Panzacchi G; Demarchi B; Busca G; Protasoni G; Golin R; Stella A
    J Hypertens; 1997 Dec; 15(12 Pt 2):1785-9. PubMed ID: 9488240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adenosine receptor agonists in the isolated, perfused rat kidney.
    Murray RD; Churchill PC
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H343-8. PubMed ID: 6089592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists.
    Murray RD; Churchill PC
    J Pharmacol Exp Ther; 1985 Jan; 232(1):189-93. PubMed ID: 2981315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs.
    Okumura M; Miura K; Yamashita Y; Yukimura T; Yamamoto K
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1262-7. PubMed ID: 1545391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenosine-receptor agonists on renin release in anaesthetized rats.
    Protasoni G; Castoldi G; Busca G; Panzacchi G; Genovesi S; Golin R; Stella A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1753-7. PubMed ID: 8903646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparate effects of adenosine A1- and A2-receptor agonists on intrarenal blood flow.
    Agmon Y; Dinour D; Brezis M
    Am J Physiol; 1993 Dec; 265(6 Pt 2):F802-6. PubMed ID: 8285213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Eur J Pharmacol; 1996 Jun; 307(2):163-9. PubMed ID: 8832218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
    Webb RL; Sills MA; Chovan JP; Peppard JV; Francis JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):287-95. PubMed ID: 8229754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists.
    Alberti C; Monopoli A; Casati C; Forlani A; Sala C; Nador B; Ongini E; Morganti A
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):320-4. PubMed ID: 9300315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats.
    Genovesi S; Pieruzzi F; Camisasca P; Ragonesi G; Protasoni G; Golin R; Zanchetti A; Stella A
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):189-94. PubMed ID: 10672849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of intrarenal adenosine by maleic acid decreases GFR and renin release.
    Arend LJ; Thompson CI; Brandt MA; Spielman WS
    Kidney Int; 1986 Nov; 30(5):656-61. PubMed ID: 3537457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposed role for adenosine in the regulation of renal hemodynamics and renin release.
    Spielman WS; Thompson CI
    Am J Physiol; 1982 May; 242(5):F423-35. PubMed ID: 7044144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine-induced decrease in renin release: dissociation from hemodynamic effects.
    Arend LJ; Haramati A; Thompson CI; Spielman WS
    Am J Physiol; 1984 Sep; 247(3 Pt 2):F447-52. PubMed ID: 6383077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile effects of adenosine, coronary flow and perfusion pressure in murine myocardium.
    Willems L; Headrick JP
    Pflugers Arch; 2007 Jan; 453(4):433-41. PubMed ID: 17072640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.